Gerald Linette

Clinical Director, Parker Institute for Cancer Immunotherapy · University of Pennsylvania Health System

Credentials: · · · ·

History

Parker Institute for Cancer Immunotherapy Center · University of Pennsylvania Health System
Present
Parker Institute Center · University of Pennsylvania Health System
Present
Cell and Vaccine Production Facility University of Pennsylvania · University of Pennsylvania Health System
Present

Next Generation T Cell Therapies for Mutant KRAS Solid Tumors
National Cancer Institute · UH3
PI · $4.6M · University of Pennsylvania
2025–2028
Next Generation T Cell Therapies for Mutant KRAS Solid Tumors
National Cancer Institute · UG3
PI · $2.7M · University of Pennsylvania
2023–2025
Extending Chimeric Antigen (CAR) T Cell Therapy to Thoracic Cancers
National Cancer Institute · P01
Project lead · $1.9M · University of Pennsylvania
2018–2024
Integrated Discovery Pipeline for Tumor Neoantigens
National Cancer Institute · R01
PI · $2.7M · University of Pennsylvania
2016–2022

Dendritic Cell Vaccination in Patients With Advanced Melanoma
Principal investigator · Completed · Phase 1
University of Pennsylvania
2017–2023
Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Principal investigator · Terminated · Phase 1, Phase 2
Adaptimmune
2011–2018
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
Principal investigator · Completed · Phase 1
University of Pennsylvania
2008–2016